# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-09T19:54:15.571623
**Route:** OpenRouter + LaTeX
**Paper Hash:** e01edaacb8bf0921
**Tokens:** 20795 in / 1685 out
**Response SHA256:** b39848d2695014b1

---

I checked the paper for fatal errors in the four categories you specified: data-design alignment, regression sanity, completeness, and internal consistency.

Findings:

- **Data-design alignment:** No fatal misalignment detected. The treatment is tied to the 2015 reform / 2017–2018 administrative reclassification, and the data extend through 2022, so there is at least one post-treatment election. The main DiD’s use of 2022 as post-treatment is internally coherent with the paper’s stated timing of full economic effect after 2020.
- **Regression sanity:** No fatal regression-output problems detected in any table. I did not find impossible values, negative SEs, R² outside [0,1], NA/NaN/Inf entries, or implausibly huge coefficients/SEs under your thresholds.
- **Completeness:** Regression tables report standard errors and sample sizes/observations. I did not find placeholder values such as TBD/TODO/XXX/NA in tables or obvious references to nonexistent numbered tables/sections.
- **Internal consistency:** I did not find a clear fatal contradiction between treatment timing, sample period, and reported specifications. There are some interpretive tensions in the paper’s narrative, but none rises to the level of a fatal internal inconsistency under your criteria.

ADVISOR VERDICT: PASS